
UK pharmaceutical company AstraZeneca yesterday rejected an improved “final” £69billion takeover offer from American drugs giant Pfizer.

Viagra maker Pfizer made its bid, worth £55 per share but AstraZeneca said it “undervalues the company” and revealed for the first time that it believed the offer should be at least £5bn more.

The latest rejection could mark the end of US-based Pfizer’s controversial attempt to snap up ­ Britain’s second-biggest - behind GlaxoSmithKline - drugs maker.

Critics had slammed Pfizer’s track record of “asset stripping” and warned the deal could hammer scientific research in the UK.

Labour welcomed AstraZeneca’s decision and accused Prime Minister David Cameron of “cheerleading for a takeover bid”.

Business Secretary Vince Cable said: “We are monitoring what is happening since the AstraZeneca board very firmly rejected the proposal, The Government’s position is unchanged.

You've turned off story recommendations. Turn them on and we'll update the list below with stories we think you'll love ( how we do this ).

You've turned off story recommendations. Turn them on and we'll update the list below with stories we think you'll love ( how we do this ).
